US pharmaceutical company B.
Lonza said its contract manufacturing business seems to be enjoying a return to form in the third quarter, despite continued …
A three-way initiative between regulatory authorities in the EU, US and Australia on the inspection of facilities making active pharmaceutical …
Mitsui & Co has taken a 5% stake in Indian active pharmaceutical ingredients manufacturer Arch Pharmalabs in a $13 million …
Nycomed has said that construction and validation of an active pharmaceutical ingredient manufacturing unit at its plant in Navi Mumbai, …
There has been progress in China on the development of drug master files for pharmaceutical ingredients and components, highlighting once …
Russian active pharmaceutical ingredient manufacturer Pharmsynthez is planning a listing on the MICEX stock exchange to help it expand beyond …
Cerbios-Pharma SA of Switzerland has officially opened its new high-potency active pharmaceutical ingredient manufacturing plant in Barbengo, a district in …
Portuguese active pharmaceutical ingredient manufacturer Hovione has posted a healthy increase in sales for the fiscal year-ended March 31, 2010, …
The European Medicines Agency carried out 175 inspections of manufacturing facilities in 2009, a little lower than its target, according …
A Chinese manufacturer has been sent a warning letter by the US Food and Drug Administration after it emerged an …
German chemical and pharmaceutical company Merck KGaA is planning to set up a plant to make inorganic salts used in …
Germany’s Evonik Industries has started up production of active pharmaceutical ingredients (APIs) at the Tippecanoe Laboratories facility acquired from Eli …
India’s Marksans Pharma is seeking approval from its shareholders to divest or lease out its two active pharmaceutical ingredient (API) …